Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-0.7x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-26.84%
202416.28%
2023105.76%
2022-8.99%
202171.12%
202037.12%
20199.35%
2018-2.60%
20171.68%
2016261.01%